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ABSTRACT
Post-translational modification of histones and
other chromosomal proteins regulates chromatin
conformation and gene activity. Methylation and
acetylation of lysyl residues are among the most
frequently described modifications in these pro-
teins. Whereas these modifications have been
studied in detail, very little is known about a recently
discovered chemical modification, the N
e-lysine
formylation, in histones and other nuclear proteins.
Here we mapped, for the first time, the sites of lysine
formylation in histones and several other nuclear
proteins. We found that core and linker histones are
formylated at multiple lysyl residues located both in
the tails and globular domains of histones. In core
histones, formylation was found at lysyl residues
known to be involved in organization of nucleosomal
particles that are frequently acetylated and methy-
lated. In linker histones and high mobility group
proteins, multiple formylation sites were mapped
to residues with important role in DNA binding.
N
e-lysine formylation in chromosomal proteins is
relatively abundant, suggesting that it may interfere
with epigenetic mechanisms governing chromatin
function, which could lead to deregulation of the cell
and disease.
Mapping of post-translational modiﬁcations of histones
has been an object of many recent studies (1–5). In depth
identiﬁcation of the modiﬁcations, their dynamics and
comparative analyses of organismal diﬀerences, are
important for understanding mechanisms of chromatin
regulation. Proteins involved in DNA binding, regulation
of chromatin condensation and DNA repair, appear to be
modulated by sequential and cooperative interplay of
a variety post-translational modiﬁcations including
acetylation, methylation and phosphorylation (6,7).
In addition to core histones (H2A, H2B, H3 and H4),
proteins such as linker histone H1, high mobility group
(HMG) and other chromosomal proteins can also
inﬂuence the regulation of chromatin function. We and
others recently showed that linker histones carry post-
translational modiﬁcation features similar to core
histones (8,9). Analyses of post-translational modiﬁca-
tions of mammalian linker histones revealed multiple sites
of acetylation, methylation, phosphorylation and formy-
lation. The latter modiﬁcation was observed at residues
that are known to be primarily involved in DNA binding
and that were also found to be acetylated or mono-
methylated. As the observed modiﬁcations were restricted
to only a few sites in H1, occurred in diﬀerent cell culture
models and tissues and with diﬀerent extraction proce-
dures, we suggested that formylation reﬂects a speciﬁc
post-translational modiﬁcation and is not an artifact
resulting from extraction and analysis procedures (9).
Supporting this argument, more recently, Jiang et al.
(10) have demonstrated that lysine formylation can arise
from oxidative damage of DNA. They showed that
30formylphosphate generated by oxidation of deoxyribose
reacts with the N
e-moiety of lysine. Due to the spatial
proximity to DNA, histones are the proteins primarily
aﬀected by this modiﬁcation. The frequency of formyla-
tion in cultured human lymphoblastoid cells TK-6 has
been estimated to be 0.1% of all lysines in acid soluble
chromatin proteins. Furthermore, in histones this value
can increase several-fold upon oxidative stress (10). Thus,
formylated lysines can reach the abundance levels of
more prominent histone modiﬁcations. Due to the
chemical similarity of N
e-acetylation and N
e-methylation
to N
e-formylation (Figure 1A), this modiﬁcation may
have functional consequences for histones.
*To whom correspondence should be addressed. Tel: +49 89 8578 2205; Fax: +49 89 8578 2219; Email: jwisniew@biochem.mpg.de
 2007 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.High-resolution mass spectrometry has become an
indispensable tool in elucidation of known and novel
modiﬁcation sites (11). In particular, the mass accuracy
achievable with modern instruments such as the linear ion
trap orbitrap mass spectrometer is at the low p.p.m. or sub-
p.p.m. level. This accuracy makes it possible to unambigu-
ously distinguish modiﬁcations that lead to the same
nominal mass shift. We have recently used these mass
spectrometric capabilities to investigate modiﬁcations in
human linker histone H1. Among several other modiﬁca-
tions, H1 proved to be formylated and we mapped the sites
of this modiﬁcation (9). In this study, we describe sites of
formylation in histones and other nuclear proteins isolated
by diﬀerent extraction methods from a variety of cultured
cell types as well as from human and mouse tissues. Our
data show that the lysyl residues aﬀected by this modiﬁca-
tion are also frequently found to be acetylated and/or
methylated.
MATERIALS AND METHODS
Tissue
Human MCF7, HeLa and A549 cells were cultured
in DMEM supplemented with 10% FBS and 1%
penicillin/streptomycin. Cells were washed with PBS, pH
7.5 and stored at  808C.
Extraction ofnuclear proteins frommouse liver
Livers were dissected from mice of the inbred strain
C57BL/6 that were sacriﬁced by decapitation. Nuclei were
isolated according to the method of Blobel and Potter (12)
with some modiﬁcations. Brieﬂy, one liver was homo-
genized in 10ml of 0.25M sucrose in buﬀer A: 10mM
Mops/NaOH, pH 7.0, 10mM NaCl, 5mM MgCl2,1m M
CaCl2, 1mM DTT containing Complete Protease
Inhibitor Cocktail (Roche Diagnostics, Mannheim,
Germany). The homogenate was loaded onto the top of
a 1.8M sucrose layer and centrifuged at 28000g in 48C for
30min. The pellet containing nuclei was resuspended in
1ml of 0.25M sucrose in Buﬀer A. Nuclei were extracted
with 1.4M ammonium sulfate and the extracts were
dialyzed against water.
Histone H1 extraction andpurification
Frozen tissues were extracted with HClO4 as described
previously (9). Brieﬂy,  200 400mg of each tissue was
blended in 0.6 1.2ml of 5% (v/v) HClO4 using an Ultra
Turbax blender (IKA, Staufen, Germany) at the max-
imum speed of approx 25000r.p.m. for 30s. The
suspension was subjected to three freezing ( 208C),
thawing and vortexing (10s) cycles. The cultured cells
were extracted in the same way but without initial
homogenization. The ﬁnal suspension was centrifuged at
15000g for 10min. Pellets were re-extracted with 0.2M
H2SO4. Both supernatants were precipitated with ice cold
100% (v/v) CCl3COOH was added to a ﬁnal concentra-
tion of 33% (v/v). The proteins were precipitated for
30min on ice and collected by centrifugation at 15000g
for 10min. The pellets were washed with 0.2% HCl in
acetone, then twice with pure acetone and vacuum-dried.
The protein pellets were solubilized in 0.1% (v/v)
CF3COOH in water and were separated on C18 reverse
phase column as described previously (9).
Digestion and LC-MS/MS analysis
Proteins were resolved on 4–12% gradient Bis-Tris gels
(NuPAGE, Novex, Invitrogen, Carlsbad, CA, USA)
and stained using Colloidal Blue Stain Kit (Novex). Gel
bands containing  0.5–2mg protein were trypsinized as
described previously (13). The resulting peptide mixtures
were desalted using in-house made C18 STAGE tips (14),
vacuum-dried and reconstituted in 0.5% acetic acid prior
to analysis. In all steps any use of formic acid or
formaldehyde was avoided.
The LC-MS/MS setup was similar to that described
before (15). The samples were injected onto an in-house
made fused-silica capillary column (15cm, inner diameter
75mm, packed with 3mm ReproSil-Pur C18-AQ media
(Dr Maisch GmbH, Ammerbuch-Entringen, Germany),
using the Agilent 1100 nanoﬂow system (Agilent
Technologies, Palo Alto, CA, USA). The LC setup was
connected to either an LTQ Orbitrap or LTQ-FT mass
spectrometer (Thermo Fisher Scientiﬁc, Bremen,
Germany) equipped with a nanoelectrospray ion source
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Figure 1. (A) Acetylated, dimethylated and formylated lysyl residues
show similar structures. (B) Complete mass separation of the otherwise
identical dimethylated and formylated peptides. Boxplot of mass
deviations from theoretical masses for formylation and dimethylation
in histone H3 measured using the LTQ-Orbitrap instrument.
The box represents the interquartile range of 25–75%, the center line
represents median, and ‘whiskers’ (small horizontal lines) extend to the
most extreme ratio up to 1.5-fold interquartile range. The mass
diﬀerences of dimethylated or formylated peptides are 28.0313 and
27.9949Da, respectively, versus unmodiﬁed peptide. Mass deviations
for dimethylation are taken from Supplementary Table S2.
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were separated with 100 or 200min gradients from 5 to
40% acetonitrile in 0.5% acetic acid. The data-dependent
acquisition mode was employed. Survey MS scans were
acquired either in the orbitrap with the resolution set to a
value of 60000 or in the FT with the resolution set to
100000. Up to 5 most intense ions per scan were
fragmented and analyzed in the linear trap. For accurate
mass measurements of the survey MS scans the lock-mass
option was used (16). Additional accurate mass measure-
ments of the fragmentation products were performed in
the orbitrap with the resolution set to 15000.
The data were searched for post-translational modiﬁca-
tions against the International Protein Index (IPI)
database with the aid of the MASCOT (Matrix Science,
London, UK) search engine (17). All relevant spectra were
veriﬁed manually.
RESULTS
With the exception of the thiol-moiety of cysteine, the
e-amine of lysine is the strongest nucleophile in proteins
and can undergo a variety of chemical reactions. These
include the reaction with formaldehyde that results in
formylation, and therefore procedures in which formalde-
hyde is used such as silver staining of gels, for example,
have to be avoided (18). In our study, three diﬀerent
protein extraction methods were used to rule out the
possibility that any of the reagents used were contami-
nated with formic acid or formaldehyde or could, directly
or indirectly, generate N
e-formylation of lysines. For this
reason histones were extracted either using 0.2M sulfuric
acid or from density gradient puriﬁed nuclei with
ammonium sulfate. Linker histones were also extracted
together with high mobility group proteins with 5%
perchloric acid. To further rule out that formylation could
be caused by particular cell culture conditions, our
analyses of core histones were performed using three
diﬀerent cultured cell types: MCF7 breast cancer cells,
HeLa cervical cancer cells and A549 lung cancer cells.
Mouse livers also were used as a source of histones. Linker
histones were prepared from MCF7 cells and from human
cancer tissues.
Identification of N
e formylated lysines
Mass spectrometry (MS) is a powerful tool for the
mapping of post-translational modiﬁcations in proteins,
but the quality of the obtained data is highly dependent on
the resolving power and mass-accuracy of the type of mass
spectrometer employed. High accuracy MS instrumenta-
tion makes it possible to diﬀerentiate between moieties of
the same nominal mass—thus helping to discern mod-
iﬁcations such as trimethylation and acetylation. The
presence of formylation on endogenous proteins was
ﬁrst suggested during in-depth proﬁling of H1 modiﬁca-
tions with the LTQ-Orbitrap instrument (19) when some
of the identiﬁed ‘dimethylated’ peptides had unusually
high deviations from their theoretical masses (9).
Dimethylation and formylation are modiﬁcations of
the same nominal mass of 28Da, but they diﬀer by
0.0364Da (Figure 1A). High-resolution mass spectro-
meters capable of mass measurement within a low p.p.m.
window can easily distinguish these mass diﬀerences.
Figure 1B shows the measured distribution of mass
deviations of formylated and dimethylated peptides of
histone H3 observed in diﬀerent runs. The graph clearly
demonstrates that these two modiﬁcations can be dis-
criminated with high conﬁdence by the accurate mass
measurement. Fragmentation signatures of a histone H3
peptide that was identiﬁed as carrying either formylation
or dimethylation are shown in Figure 2. Lysine-80 in the
peptide 74–84 is the modiﬁcation site. The fragmentation
Figure 2. The MS/MS fragmentation spectra of (A) EIAQDFfKTDLR
formylated and (B) EIAQDFdmKTDLR dimethylated peptides of
Histone H3. The major groups of ions produced on cleavage of
peptide bonds by low energy collision fragmentation are b ions
extending from the N-terminus of a peptide, and y ions extending
from its C-terminal part. The comprehensive introduction to
the peptide sequencing by mass spectrometry is given by Steen and
Mann (33).
572 Nucleic Acids Research, 2008, Vol. 36, No. 2Figure 3. High accuracy MS/MS spectra of peptides dimethylated (A, C, E) and formylated (B, D, F) at the same residue, respectively. (A and B)
Modiﬁcations at K-108 in histone H2B. (C and D) Modiﬁcations at K-43 in histone H2B. (E and F) Modiﬁcations at K-77 in histone H4. In contrast
to dimethylation, formylation was observed mainly on peptides that were not cut at the modiﬁed lysyl residue. An example of the MS and MS/MS
data interpretation: after the MS scan, the ESYSVYVYKVLK peptide (B) was identiﬁed as carrying an extra mass of 27.995Da that corresponds to
the delta mass of formylation. Peptide fragmentation analysis reveals that, starting from y4 ion (KVLK), the formyl group is added to y-ion series.
The observations, additionally supported by the presence of b10 (ESYSVYVYKV) and b11 (ESYSVYVYKVL) ions with the mass shift indicative of
formylation, unambiguously position the modiﬁcation at the middle lysyl residue—ESYSVYVYfKVLK. Average absolute mass accuracy of all
assigned peaks was better than 2p.p.m.
Nucleic Acids Research,2008, Vol. 36,No. 2 573spectra appear almost identical when acquired in the low
accuracy linear ion trap detection mode, and, without the
knowledge gained from the high accuracy peptide mass
measurement would likely have been misidentiﬁed. A
lysine to arginine mutation could in principle also be the
cause of a nominal mass increase of 28Da (28.00615Da).
However, the diﬀerence of 0.01123Da between this
modiﬁcation and formylation is easily discriminated by
high accuracy mass spectrometry. In Figure 3, examples of
high accuracy fragmentation spectra of peptides dimethy-
lated and formylated at the same residue are shown. We
have observed that trypsin cuts only weakly at the N-site
of formylated lysine, what is in contrast to its activity on
dimethylated lysine. Therefore identiﬁcation of both
modiﬁcations at the same residue was often possible
only on peptides with diﬀerent lengths. For this reason, it
is diﬃcult to make conclusions on the ratio of the
abundances of dimethylation and formylation comparing
the intensities of the relevant peptides in the chromato-
gram. Only in seldom cases, when a dimethylated peptide
was miscleaved at the C-site of the dimethylated residue, a
comparison of the ratios of both modiﬁcations at the same
site was possible (Figure 4). For the peptide
LLLPGELA
 K from histone H2B (HeLa cells) formyla-
tion appears to be less abundant than dimethylation
(Figure 4). Interestingly, the formylated peptide shows
increased retention in comparison to its dimethylated
version (Figure 4).
In this study, we isolated histones and other nuclear
proteins from diﬀerent cell types and tissues. These
protein mixtures were digested with trypsin and online
analyzed on the LTQ-Orbitrap as described in Materials
and Methods section. Only the formylation sites observed
at least in two analyses are presented in Table S1. In total
we identiﬁed 165 peptides containing N
e-formyl lysine
using high accuracy mass spectrometry (Supplementary
Table S1). They represent 47 unique formylation sites in
core and linker histones, high mobility group proteins and
two other proteins (Table 1).
Core histones
Our analysis allowed identiﬁcation of 19 N
e-lysine
formylation sites in core histones that were located in
their N-terminal tails and globular domains. Two sites of
formylation were found in the tail of histone H3 and three
in its globular domain (Table 1). The sites at K-18 and
K-23 that are located in the tail of H3 are known to occur
in both acetylated and methylated forms (3). In the core of
H3 we identiﬁed formylation at K-64, K-79 and K-122.
Methylation or dimethylation of these residues have been
previously reported (20).
In histone H4, we identiﬁed one formylation site in the
tail (K-12) and ﬁve sites in its globular domain. This site is
functionally important because acetylated K-12 is selec-
tively targeted by the BRD2 bromodomain and activates
transcription from the cyclin E promoter (21). In histone
H2A, three sites of formylation at K-36, K-95 and K-118
were mapped to the globular domain of the histone,
whereas in histone H2B a site in the tail K-5 and four sites
in the core of this histone were mapped at K-34, K-44,
K-47 and K109. Lysine H2B-K-5 is known to be
acetylated.
These data show that formylation often occurs at
residues that can also be methylated and acetylated.
Clearly, formylation of these sites prevents subsequent
methylation and acetylation. Since many of those mod-
iﬁcations are important in chromatin regulation, formyla-
tion could interfere with this process.
In the nucleosomal particles some of the histone lysyl
moieties are involved in direct interactions with DNA
(22). These include residues H3-K64, H4-K79, H2B-K34
that we identiﬁed in a formylated state and that create
main chain interactions with DNA. Additionally, we
measured formylation on H4-K77, which sits in the major
groove of DNA (22). Thus, formylation of lysyl residues
may also impair organization of the nucleosomes.
Linker histones
Analysis of linker histones revealed formylated lysines
distributed over all three structural domains of these
proteins: the N-terminal tail, the central domain and the
C-terminal tail. For the most abundant H1 variant in
human cells, the H1.4 protein, we identiﬁed 12 sites of
formylation (Table 1). Seven of these sites are located in
the central domain and three of them, K-64, K-85 and
K-97 (H1.4 residue numbering), at residues involved in
DNA binding (23,24). Since formylation, similar to
acetylation, can interfere with DNA binding, it is possible
that these modiﬁcations can signiﬁcantly change the
binding properties of H1. It is interesting in this context
that nine of the formylated sites were previously identiﬁed
as acetylated.
Figure 4. Dimethylated (dm) and formylated (f) forms of the peptide
LLLPGELA
 K (from histone H2B; K-108) resolved by chromatogra-
phy. Inserts show the mass envelopes of dimethylated and formylated
peptides.
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Formylation sites were found in each on the dominant
members of the high mobility group protein families
HMGA, HMGB and HMGN. Formylation of K-31 in
HMGA1 is located in one of the three DNA-binding
domains of this protein. HMGN2 is the most abundant of
the nucleosome-binding proteins and we found formyla-
tion in its nucleosome-binding domain. In the HMGB1
protein, four diﬀerent formylation sites were mapped.
Three sites are located in the HMG-box domains (K-59,
Table 1. Formylation sites identiﬁed in human and mouse tissues
Protein Peptide Site Domain Occurrence of formylation (times)
MCF7 (3)
a MCF7 (2) HeLa (3) A543 (3) Mouse
liver (2)
Human
cancer
b (3)
Extraction method
HClO4 H2SO4 H2SO4 H2SO4 Salt HClO4
H1.2 Ac-SETAPAAPAAAPPAEfKAPVK K-17 N-tail 2 2
H1.4 Ac-SETAPAAPAAPAPAEfKTPVK K-17 N-tail 2 2
H1.2–H1.4 fKASGPPVSELITK K-34 GH1 3
H1.5 fKATGPPVSELITK K-37 GH1 2
H1.2–H1.4 ASGPPVSELITfKAVAASK K-46 GH1 1 2
H1.1–H1.4 SGVSLAALfKK K-63 GH1 3
H1.1–H1.4 fKALAAAGYDVEK K-64 GH1 3
H1.4 ERSGVSLAALfK K-64 GH1 3
H1.5 fKALAAGGYDVEK K-67 GH1 2
H1.1–H1.4 ALAAAGYDVEfK K-75 GH1 2
H1.1–H1.5 LGLfKSLVSK K-85 GH1 2 3
H1.1–H1.4 SLVSfKGTLVQTK K-90 GH1 2
H1.1–H1.4 GTLVQTfKGTGASGSFK K-97 GH1 3
H1.4 fKAASGEAKPK K-110 C-tail 2
H1.4 fKATGAATPK K-140 C-tail 1 1
H1.3 fKVAGAATPK K-141 C-tail 2
H1.3; H1.4 fKPAAAAGAK K-160 C-tail 2
H1.2 fKPAAATVTK K-160 C-tail 2
H2A fKGNYAER K-36 Core 1 1
H2A NDEELNfKLLGK K-95 Core 1 2 2 1
H2A VTIAQGGVLPNIQAVLLPfKK K-118 Core 2 2 2
H2B PEPAfKSAPAPK K-5 N-tail 1 2
H2B fKESYSVYVYK K-34 Core 2 2 2 1
H2B ESYSVYVYfKVLK K-43 Core 1 1
H2B VLfKQVHPDTGISSK K-45 Core 2
H2B LLLPGELAfK K-107 Core 2 3 1 2
H3 fKQLATaKAAR, fKQLATK K-18 N-tail 2 2 2 2
H3 QLATfKAAR K-23 N-tail 2
H3 fKLPFQR K-64 Core 1 3 2
H3 EIAQDFfKTDLR K-79 Core 2 3 2 1
H3 VTIMPfKDIQLAR K-122 Core 2 1 1
H4 GLGfKGGAaKR K-12 N-tail 2 1 1
H4 DNIQGITfKPAIR K-31 N-tail 2 3 2 2
H4 GVLfKVFLENVIR K59 Core 2
H4 DAVTYTEHAfK K-77 Core 1 2 1
H4 fKTVTAMDVVYALK K-79 Core 3 1
H4 TVTAMDVVYALfKR K-91 Core 2 1
HMGB1 GfKFEDoxMAK K-59 HMG box A 2
HMGB1 FfKDPNAPK K-90 2 2
HMGB1 IfKGEHPGLSIGDVAK K-114 HMG box B 1 1
HMGB1 YEfKDIAAYR K-157 HMG box B 2
HMGN2 LSAfKPAPPKPEPK K-31 NBD1
c 2
HMGA1 fKQPPVSPGTALVGSQK K-31 DBD2
d 2
Lamin A/C LfKDLEALLNSK K-135 2 1
Calgizzarin Ac-AfKISSPTETER K-2 2
Calgizzarin NQfKDPGVLDR K-55 2
Calgizzarin YAGfKDGYNYTLSK K-27 2
aNumber of independent experiments.
bSingle samples of breast ductal, colon, and ovarian cancer were analyzed.
cNBD, nucleosomes-binding domain.
dDBD, DNA-binding domain.
‘Shaded areas’ indicate that HClO4 extracts do not contain core histones and lamin A/C; in sulfuric acid extracts only protein bands containing core
histones were analyzed; in salt extracts of mouse liver HMGN1 and HMGA1 were not identiﬁed; and in cancer samples only fractions containing
linker histones were analyzed.
Nucleic Acids Research,2008, Vol. 36,No. 2 575K-114 and K-157 and in the linker between the domains
(K-90). K-114 plays an important role in interaction with
DNA, because mutation of this residue results in
signiﬁcant loss of DNA-binding aﬃnity and supercoiling
activity of the HMG-box B-domain (25).
Otherproteins
Calgizzarin, also known as S100A11, is a calcium-binding
protein implicated in a variety of biologic functions such
as proliferation and diﬀerentiation, as well as in cancer.
For a long time cellular localization of this protein was
obscure, but recently calgizzarin was identiﬁed in nuclear
fractions from cultured cells (26). We observed three
formylation sites in this protein. Lamins are components
of the nuclear lamina, a ﬁbrous layer on the nucleoplasmic
side of the inner nuclear membrane, which is thought to
provide a framework for the nuclear envelope and may
also interact with chromatin. Identiﬁcation of formylation
of K-135 in lamin A/C suggests that this residue may be
located in the vicinity of DNA.
DISCUSSION
Recently, formylation has been recognized as a novel post-
translational modiﬁcation of lysine that occurs in histones
(9,10). The two previous studies had mapped none (10) or
three sites in a single protein (9). In this study, we have
considerably extended our knowledge of the occurrence of
this post-translational modiﬁcation in histones and other
nuclear proteins by proteomic mapping of 48 formylated
sites in 10 diﬀerent proteins. We took advantage of the
high-mass accuracy of modern MS instrumentation that
allowed unambiguous discrimination between dimethyla-
tion (28.0313Da) and formylation (27.9949Da). In addi-
tion, both modiﬁcations can be distinguished by diﬀerent
LC-retention times. We observed that formylation can
aﬀect lysyl residues important for interaction with DNA
and also those modiﬁed by acetylation and methylation.
Thus, formylation can impair the function of histones by
interfering with the histone code-mediated formation and
stabilization of binding sites for regulatory proteins such
as transcription factors and regulators of chromatin
activity.
Histone H1 was found to be the most frequently
formylated among histones. Whereas in four core histones
19 formylation sites were identiﬁed altogether, in the
most abundant linker histone variant H1.4 thirteen
formyl-lysines were mapped. The higher number of H1
formylation sites correlates with the high degree of H1
formylation observed previously (10). The abundance
of formylation in all three structural domains of H1 may
reﬂect the fact that, similarly to the DNA-binding domain,
both N-terminal and C-terminal tails are in close contact
with DNA.
Since histones and some other chromosomal proteins
have slow turnover rates (27–29), lysine formylation could
accumulate with age and contribute to deregulation of
chromatin function. Furthermore, lysine formylation is
stimulated by oxidative stress (10) and, therefore, this
modiﬁcation may be involved in development of diseases
linked to this stress, including cancer. In fact, lysine
formylation may be involved in loss of protein function in
the organism in an analogous way to other chemical
modiﬁcations, such as glycation in diabetes (30) or
oxidative damage in aging (31,32).
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